Issue 10, 2013

Pluronic L61 as a long-circulating modifier for enhanced liposomal delivery of cancer drugs

Abstract

Pluronic copolymer L61 was found to possess a stealth function for liposomal drug delivery, comparing favorably to PEG. The liposomes modified with 0.1% L61 (w/w) were long-circulating, and preferentially accumulated in the tumor site. The paclitaxel-loaded L61-liposomes with a single injection dose could successfully arrest the tumor growth, lasting for five days, and displayed better treatment outcomes compared to the non-modified liposomes and even the PEGylated liposomes.

Graphical abstract: Pluronic L61 as a long-circulating modifier for enhanced liposomal delivery of cancer drugs

Supplementary files

Article information

Article type
Communication
Submitted
09 Jan 2013
Accepted
26 Mar 2013
First published
27 Mar 2013

Polym. Chem., 2013,4, 2958-2962

Pluronic L61 as a long-circulating modifier for enhanced liposomal delivery of cancer drugs

Y. Wang, E. Liu, X. Sun, P. Huang, H. Long, H. Wang, X. Yu, C. Zheng and Y. Huang, Polym. Chem., 2013, 4, 2958 DOI: 10.1039/C3PY00042G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements